Search

Inovio Pharmaceuticals Inc

Open

SectorHealthcare

1.46 -3.31

Overview

Share price change

24h

Current

Min

1.34

Max

1.5899999999999999

Key metrics

By Trading Economics

Income

14M

-6M

Employees

112

EBITDA

3.3M

-18M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+366.39% upside

Dividends

By Acuity

Next Earnings

10 lis 2026

Market Stats

By TradingEconomics

Market Cap

56M

160M

Previous open

4.77

Previous close

1.46

Inovio Pharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

9 lis 2026, 23:51 UTC

News

Jefferies maintains a Buy rating on Airbnb, Inc. and raises its price target to $230, citing confidence in the company's growth prospects.

9 lis 2026, 23:51 UTC

News

EVI Industries reports Q1 earnings of $0.24 per share, exceeding estimates, with revenue of $112.948 million and a 108% increase in net income to $3.847 million.

9 lis 2026, 23:51 UTC

News
Event

Mesa Laboratories reports Q2 net income of $4.34 million, revenue of $62.34 million, and projects full-year revenue of $250M to $255M.

9 lis 2026, 23:41 UTC

News

Steady as U.S. wholesale inventories rose in September.

9 lis 2026, 23:26 UTC

News

U.S. Nuclear Regulatory Commission grants Dow Inc. a construction permit for four Xe-100 small modular reactors at its UCC Seadrift Operations site in Texas.

9 lis 2026, 23:21 UTC

News

Under Armour's price declines in after-market trading after Telsey Advisory Group lowered its price target to $5 while maintaining a Market Perform rating.

9 lis 2026, 23:21 UTC

News

Amazon.com Inc announced that OpenAI's ChatGPT Enterprise is now available through AWS Marketplace, enhancing its position in the AI market.

9 lis 2026, 23:21 UTC

News

Telsey Advisory Group maintained a Market Perform rating on Under Armour Inc and lowered its price target to $5 in a report published after the market closed.

9 lis 2026, 23:16 UTC

Correlated Moves
News

Moody's upgraded SM Energy Co's corporate family rating to Ba2 from Ba3, citing significant balance-sheet improvement and reduced debt of $6.8 billion.

9 lis 2026, 23:16 UTC

News

Steel Dynamics announces a $3.0 billion share repurchase program and declares a quarterly cash dividend of $0.53 per share, payable January 8, 2027.

9 lis 2026, 23:16 UTC

News

Teradyne, Inc. announced a quarterly cash dividend of $0.13 per share, payable on December 16, 2026, to shareholders on record as of November 23, 2026.

9 lis 2026, 23:16 UTC

News

Coherus Oncology reports Q3 2026 revenue of $14.3M, up from $11.6M year-over-year, and announces a strategic plan with a 30% workforce reduction.

9 lis 2026, 23:12 UTC

News

Apollo Global Management, Inc. has priced a $600 million offering of 7.550% Fixed-Rate Resettable Junior Subordinated Notes due 2056, closing on November 13, 2026.

9 lis 2026, 23:11 UTC

Social Media
News

NVIDIA's stock price advanced after former President Trump expressed confidence in CEO Jensen Huang amid an FBI investigation into allegations involving a suspected Chinese spy.

9 lis 2026, 23:11 UTC

News

Jefferies maintains Hold rating on Duolingo, Inc. while raising price target to $175, reflecting the firm's assessment of the company's market position and growth potential.

9 lis 2026, 23:11 UTC

News

Orrstown Financial Services announces a strategic repositioning of its AFS securities portfolio, involving a $185.6 million sale and a $13.8 million pre-tax loss.

9 lis 2026, 23:06 UTC

News

Grab Holdings Limited reported third-quarter revenue above estimates and record adjusted EBITDA, but the stock is trading modestly lower in after-market hours.

9 lis 2026, 23:06 UTC

News

Constellation Energy Corp shares are trading modestly lower in after-market hours, following a notable decline after the market closed.

9 lis 2026, 23:06 UTC

News

Syndax Pharmaceuticals grants CFO Aaron A. Ondrey an inducement award for 270k shares at an exercise price vesting over four years, approved by the Board.

9 lis 2026, 23:06 UTC

News

Northrop Grumman Corp will not contest its loss of the $20B F/A-XX Navy fighter program to Boeing, with shares trading flat in after-market hours.

9 lis 2026, 23:02 UTC

News

Xenon Pharmaceuticals reports a Q3 net loss of $110.4 million, better than the expected $113 million loss, with operating expenses rising to $120.1 million.

9 lis 2026, 23:02 UTC

News

FutureFuel Corp reported a net loss of $8.4 million for Q3, despite a revenue increase to $104.7 million driven by strong biodiesel demand.

9 lis 2026, 23:02 UTC

Social Media
News

AbCellera Biologics reports Q3 2026 revenue of $10.63 million, surpassing estimates, and a net loss of $40.8 million, improved from last year.

9 lis 2026, 23:02 UTC

Social Media
News

Harrow, Inc. reported record Q3 revenue of $99.3 million and GAAP net income of $9.8 million, a turnaround from a loss last quarter.

9 lis 2026, 23:02 UTC

Social Media
News

Hims & Hers Health, Inc. reported a Q3 net loss of $33 million and lowered its Q4 revenue outlook, missing analyst expectations.

9 lis 2026, 23:02 UTC

News

Paysign Inc reported Q3 earnings with EPS of $0.11 and revenue of $30.8 million, raising full-year 2026 GAAP EPS guidance to $0.37-$0.38.

9 lis 2026, 23:02 UTC

News

First Advantage Corporation launches a secondary offering of 15 million shares by Silver Lake Group, with no proceeds going to the company.

9 lis 2026, 23:02 UTC

News
Social Media

Plug Power Inc. reported Q3 2026 revenue of approximately $201 million, a 13% increase, and a GAAP EPS of $0.07, improving from a loss of $0.31.

9 lis 2026, 23:02 UTC

News

Cantor Fitzgerald initiates coverage on DICK'S Sporting Goods with a Neutral rating and a price target of $146.00.

9 lis 2026, 23:02 UTC

News
Social Media

AAON, Inc. reported record third-quarter net sales of $707.4 million, exceeding expectations, and raised its full-year revenue growth outlook to 72%-75%.

Peer Comparison

Price change

Inovio Pharmaceuticals Inc Forecast

Price Target

By TipRanks

366.39% upside

12 Months Forecast

Average 5.667 USD  366.39%

High 8 USD

Low 4 USD

Based on 3 Wall Street analysts offering 12 month price targets forInovio Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat